Abpro Corporation IPO Research Information

Abpro Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Abpro Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Abpro Corporation	ABP - NASDAQ	Withdrawn	$0.00	$0.00	Withdrawn	5/11/2018
Underwriter(s): UBS Investment Bank, Wells Fargo Securities, Nomura, Oppenheimer & Co.
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-04-11 Terms Added 2018-05-02

About Abpro Corporation (adapted from Abpro Corporation prospectus):
They are a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ABP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.